← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Vaxin Inc.
Birmingham, AL
$8,025,067
Total funding
13
Grants
Funding over time
peak $5.4M · FY2005–12$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
Funding mix
By agency
NIH$8,025,067 · 13
By mechanism
UC1$5,435,173 · 2
R44$952,146 · 1
R42$565,250 · 1
R43$422,498 · 4
R41$400,000 · 4
R21$250,000 · 1
Investigators at Vaxin Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Pandemic Infleuenza Virus Vaccines$3,000,000
UC1 · FY2005 · AI
Adenovirus-vectored nasal anthrax vaccine$2,435,173
UC1 · FY2005 · AI
In-ovo vaccination/avian influenza/bird/human$342,163
R44 · FY2010 · AI
In-ovo vaccination/avian influenza/bird/human$332,379
R44 · FY2008 · AI
Non-invasive delivery of skin-targeted tetanus vaccines$282,625
R42 · FY2002 · AI
Non-invasive delivery of skin-targeted tetanus vaccines$282,625
R42 · FY2001 · AI
In-ovo vaccination/avian influenza/bird/human$277,604
R44 · FY2009 · AI
Modified adenovirus with selective tropism in Langerhans$125,000
R21 · FY2002 · AI
Modified adenovirus with selective tropism in Langerhans$125,000
R21 · FY2003 · AI
In-ovo vaccination/avian influenza/bird/human$111,797
R43 · FY2006 · AI
Development of a simple and effective therapy against post-exposure anthrax$110,701
R43 · FY2012 · AI
NONINVASIVE DELIVERY OF SKIN-TARGETED RABIES VACCINES$100,000
R43 · FY2001 · AI
Adenovirus vectored vaccines for Alzheimer's disease$100,000
R41 · FY2007 · AG
Immuno-enhancement of skin patch anthrax vaccination$100,000
R41 · FY2002 · AI
Skin-patch Vaccination against Alzheimer's Disease$100,000
R41 · FY2002 · AG
Acne Vaccines Targeting a Surface Sialidase and a Secreted CAMP Factor Toxin$100,000
R41 · FY2008 · AR
Noninvasive delivery of skin-targeted anthrax vaccines$100,000
R43 · FY2001 · AI